ArticlePharmaceuticals (Basel, Switzerland)2023

Evaluation of Brain Targeting and Antipsychotic Activity of Nasally Administrated Ziprasidone Lipid-Polymer Hybrid Nanocarriers.

Hadel A Abo El-Enin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.